Session 1: Drug Eluting Technologies: Where Have We Come Since the Paradise Trial?

Discussant(s)

• 

  Barry Katzen, MD, FACC, FACR, FSIR

  Founder & Chief Medical Executive
  Interventional Radiology
  Miami Cardiac & Vascular Institute
  FIU Herbert Wertheim College of Medicine
  Miami, Florida
• RN

  Richard Neville, MD

  Chairman, Department of Surgery, Associate Director, INOVA Heart and Vascular Institute
  INOVA Health system
  University of Virginia, George Washington University
  Falls Church, Virginia
• 

  Sevan Oungoulian, PhD

  General Engineer
  US Food and Drug Administration
  Orinda, California
• 

  Bruno Scheller, Univ.-Prof. Dr.

  Universitaetsprofessor
  Clinical and Experimental Interventional Cardiology, University of Saarland
  University of Saarland
  Homburg Saar, Saarland, Germany
• 

  Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

  Director of Vascular Interventon
  Beth Israel Deaconess Medical Center, Harvard Medical School
  Harvard Medical School
  Boston, Massachusetts
• 

  Ramon Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)

  Vascular Surgeon
  Prince of Wales Hospital
  University of New South Wales
  Randwick, New South Wales, Australia
• 

  Craig Walker, MD

  Founder/President/Medical Director
  Cardiovascular Institute of the South
  Tulane Medical School / LSU School Medicine
  Houma, Louisiana
• 

  Thomas Zeller, MD

  Director Department Angiology
  Interventional Angiology
  Angiology Universitaets-Herzzentrum Freiburg - Bad Krozingen
  University Freiburg
  Bad Krozingen, Baden-Wurttemberg, Germany

Moderator(s)

• 

  Marianne Brodmann, MD

  Professor
  Division of Angiology Medical University Graz
  Medical University Graz
  Graz, Steiermark, Austria

Speaker(s)

• 

  Bruno Scheller, Univ.-Prof. Dr.

  Universitaetsprofessor
  Clinical and Experimental Interventional Cardiology, University of Saarland
  University of Saarland
  Homburg Saar, Saarland, Germany

  PDF Slides
• 

  Eric Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM

  Director of Vascular Interventon
  Beth Israel Deaconess Medical Center, Harvard Medical School
  Harvard Medical School
  Boston, Massachusetts

  PDF Slides
• 

  Ramon Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi)

  Vascular Surgeon
  Prince of Wales Hospital
  University of New South Wales
  Randwick, New South Wales, Australia

  PDF Slides
• 

  Craig Walker, MD

  Founder/President/Medical Director
  Cardiovascular Institute of the South
  Tulane Medical School / LSU School Medicine
  Houma, Louisiana

  PDF Slides
• 

  Thomas Zeller, MD

  Director Department Angiology
  Interventional Angiology
  Angiology Universitaets-Herzzentrum Freiburg - Bad Krozingen
  University Freiburg
  Bad Krozingen, Baden-Wurttemberg, Germany

  PDF Slides

Presentations:

• 8:30 AM – 8:40 AM CT

  Welcome Remarks. A Tribute to Andy Feiring, MD
  

  Speaker: Marianne Brodmann, MD – Division of Angiology Medical University Graz
• 8:40 AM – 9:10 AM CT

  Dr. Andy Feiring Keynote Address: Historical Perspective of Drug-Eluting Devices. Where are we Today and Where do we Need to go for CLI?
  

  Speaker: Bruno Scheller, Univ.-Prof. Dr. – Clinical and Experimental Interventional Cardiology, University of Saarland
• 9:10 AM – 9:20 AM CT

  The Pharmacokinetics of Paclitaxel and Limus
  

  Speaker: Marianne Brodmann, MD – Division of Angiology Medical University Graz
• 9:20 AM – 9:30 AM CT

  FDA Determination: Data Does Not Support an Excess Mortality Risk for Paclitaxel-Coated Device
  

  Speaker: Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) – Prince of Wales Hospital
• 9:30 AM – 9:40 AM CT

  The Value of Debulking and Vessel Prep Before Drug Delivery
  

  Speaker: Craig M. Walker, MD – Cardiovascular Institute of the South
• 9:40 AM – 9:50 AM CT

  Is IVUS the Answer to 1:1 Ratio between Drug Delivery Devices and Vessel Diameter?
  

  Speaker: Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM – Beth Israel Deaconess Medical Center, Harvard Medical School
• 9:50 AM – 10:00 AM CT

  Alternative Methods for Drug Delivery
  

  Speaker: Thomas Zeller, MD – Angiology Universitaets-Herzzentrum Freiburg - Bad Krozingen
• 10:00 AM – 10:10 AM CT

  Panel Discussion
  

  Discussant: Bruno Scheller, Univ.-Prof. Dr. – Clinical and Experimental Interventional Cardiology, University of Saarland

  Moderator: Marianne Brodmann, MD – Division of Angiology Medical University Graz

  Discussant: Craig M. Walker, MD – Cardiovascular Institute of the South

  Discussant: Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM – Beth Israel Deaconess Medical Center, Harvard Medical School

  Discussant: Thomas Zeller, MD – Angiology Universitaets-Herzzentrum Freiburg - Bad Krozingen

  Discussant: Barry T. Katzen, MD, FACC, FACR, FSIR – Miami Cardiac & Vascular Institute

  Discussant: Richard F. Neville, MD – INOVA Health system

  Discussant: Sevan Oungoulian, PhD – US Food and Drug Administration

  Discussant: Ramon L. Varcoe, MBBS, MS, FRACS, PhD, MMed (ClinEpi) – Prince of Wales Hospital